Stockchase Opinions

Scott Willis ABcann Global Corp. ABCN-X COMMENT Jun 29, 2018

Future? Produces plant-based medicine. They’re smart, likes the management team because of their pharma experience. Oversupply still to get through, but if you’re willing to look beyond the next year, stick with it. If you’re worried about storm clouds, put your money into a high-yielding energy stock, or another commodity, and then come back in later in 2019.

$1.350

Stock price when the opinion was issued

0
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

WATCH

It does look interesting. They have an expansion plan. He thinks the caller might be onto something. He would not run out and buy it because the valuation is still $150 Million.

DON'T BUY

He thinks the smaller and intermediate producers are going to have a tough time making money in weed as the big 4 continue to lower costs and raise capital at lower costs.